Biggest News Aggregation in the World

All Doses News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from All Doses. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In All Doses Today - Breaking & Trending Today

Artax Biopharma Announces Positive Phase 1 Results for AX-158, Company's First-in-Class Oral Immunomodulator Developed to Treat T Cell-Mediated Diseases - Vimarsana News

Artax Biopharma Announces Positive Phase 1 Results for AX-158, Company's First-in-Class Oral Immunomodulator Developed to Treat T Cell-Mediated Diseases

Published: June 1, 2023

/PRNewswire/ -- Artax Biopharma, Inc., a clinical-stage biotechnology company focused on transforming the treatment of T Cell-mediated diseases, today...

Source: prnewswire.com

Related Topics:

United Kingdom Joseph Lobacki Clinical Development Efforts Prnewswire Artax Biopharma Inc Findings Demonstrated Investigational Agent Well Tolerated All Doses Strongly Supports Further Clinical Development Being Developed Once Daily Oral Dosing Address Autoimmune Diseases Providing Immunomodulation Officer Joseph Artax Biopharma Health Care Amp Hospitals Medical Pharmaceuticals Pharmaceuticals Clinical Trials Amp Medical Discoveries